Beazley (LSE:BEZ)
Set up in 1986, Beazley is a Lloyds of London insurer. It specialises in writing specialty-risk insurance and reinsurance business. The company floated on the stock market in 2004, and has also established a US operation.
About
Last updated 13-12-2019, 04:30:00pm GMTRelated Articles
-
Forget buy-to-let! Here’s how I think these 2 FTSE 250 bargains can help you make a million
The returns from buy-to-let are falling, but these FTSE 250 stocks should report double-digit earnings growth in the next few years, says Rupert Hargreaves.... Read More »
-
A FTSE 250 stock I’d buy to complement the Aviva share price
The Aviva plc (LON: AV) share price looks cheap to me, but so does this FTSE 250 (INDEXFTSE: MCX) prospect. Read More »
-
£3k to invest? 2 ‘hidden’ FTSE 250 dividend giants I’d buy and hold for 10 years
Roland Head highlights two FTSE 250 (INDEXFTSE:MCX) stocks that could diversify a dividend portfolio. Read More »
-
Is Marks and Spencer’s share price a steal after this news?
Could Marks and Spencer Group plc (LON: MKS) offer value investing potential? Read More »
-
Have £1,000 to invest? Why I believe you can’t go wrong with this FTSE 250 income champ
This FTSE 250 (INDEXFTSE: MCX) stock has made its investors millions already, Rupert Hargreaves explains why this is set to continue. Read More »
-
Why the Saga share price could be heading back to 200p
Roland Head revisits his buy recommendation on Saga plc (LON:SAGA) and considers another troubled insurer. Read More »
-
AstraZeneca plc isn’t the only dividend stock I’d hold for the next decade
Roland Head explains why AstraZeneca plc (LON:AZN) could be a smart long-term buy. Read More »
-
2 Warren Buffett-style stocks to help you make a million
You can become rich investing like Warren Buffett. Read More »
-
Buying these 2 stocks now could make you a million for retirement
These two stocks have a long history of producing enormous returns for investors. Read More »
-
Why these ‘overvalued’ dividend stocks could be takeover targets
Roland Head explains why these top performers could still be cheap. Read More »